Heartburn cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
Jose Loyola (talk | contribs) |
Amir Bagheri (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The use of [[proton pump inhibitors]] for 8 weeks associated with lifestyle modifications is a cost-saving strategy in patients with | The use of [[proton pump inhibitors]] for 8 weeks associated with lifestyle modifications is a cost-saving strategy in patients with [[heartburn]] and [[gastroesophageal reflux disease]] ([[GERD]]). | ||
==Cost-effectiveness of Therapy== | ==Cost-effectiveness of Therapy== | ||
*A study from Stanford University School of Medicine revealed that "an 8-wk course of PPIs for initial symptom relief, followed by repeat courses of therapy initiated when symptoms recur, is more cost-effective than step-up or step-down strategies, or continuous therapy with either H2RAs or PPIs."<ref name="pmid10685741">{{cite journal| author=Gerson LB, Robbins AS, Garber A, Hornberger J, Triadafilopoulos G| title=A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease. | journal=Am J Gastroenterol | year= 2000 | volume= 95 | issue= 2 | pages= 395-407 | pmid=10685741 | doi=10.1111/j.1572-0241.2000.01759.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10685741 }} </ref> | *A study from Stanford University School of Medicine revealed that "an 8-wk course of PPIs for initial symptom relief, followed by repeat courses of therapy initiated when symptoms recur, is more cost-effective than step-up or step-down strategies, or continuous therapy with either H2RAs or PPIs."<ref name="pmid10685741">{{cite journal| author=Gerson LB, Robbins AS, Garber A, Hornberger J, Triadafilopoulos G| title=A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease. | journal=Am J Gastroenterol | year= 2000 | volume= 95 | issue= 2 | pages= 395-407 | pmid=10685741 | doi=10.1111/j.1572-0241.2000.01759.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10685741 }} </ref> | ||
* Costs estimated for the treatment of [[GERD]] according to the medication and regimen - considering mild [[GERD]] from 40yrs until death (in 1999 US dollars): | *Costs estimated for the treatment of [[GERD]] according to the medication and regimen - considering mild [[GERD]] from 40yrs until death (in 1999 US dollars): | ||
**Lifestyle - $0 | **Lifestyle - $0 | ||
**PPI-on-demand - $26,167 | **PPI-on-demand - $26,167 | ||
| Line 20: | Line 20: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:General practice]] | [[Category:General practice]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Digestive disease symptoms]] | [[Category:Digestive disease symptoms]] | ||
Latest revision as of 23:04, 27 October 2020
|
Heartburn Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Heartburn cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Heartburn cost-effectiveness of therapy |
|
Risk calculators and risk factors for Heartburn cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: José Eduardo Riceto Loyola Junior, M.D.[2]
Overview
The use of proton pump inhibitors for 8 weeks associated with lifestyle modifications is a cost-saving strategy in patients with heartburn and gastroesophageal reflux disease (GERD).
Cost-effectiveness of Therapy
- A study from Stanford University School of Medicine revealed that "an 8-wk course of PPIs for initial symptom relief, followed by repeat courses of therapy initiated when symptoms recur, is more cost-effective than step-up or step-down strategies, or continuous therapy with either H2RAs or PPIs."[1]
- Costs estimated for the treatment of GERD according to the medication and regimen - considering mild GERD from 40yrs until death (in 1999 US dollars):
- Lifestyle - $0
- PPI-on-demand - $26,167
- H2RA-PPI - $27,846
- H2RA - $29,965
- Step down - $37,641
- PPI, continuous - $41,112
- Laparoscopic Nissen fundoplication (includes 2-day hospital stay) - approximately - $11,064.87
- Considering that the complications Barrett's esophagus may lead to esophageal cancer which presents with a much more costlier treatment, the on-demand PPI-therapy is the most cost-effective treatment available. The paper also stated that even thought it is the most cost-effective choice, it was the least used. The study was performed in 2000, which may cause its results to vary dramatically in more recent times.
References
- ↑ Gerson LB, Robbins AS, Garber A, Hornberger J, Triadafilopoulos G (2000). "A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease". Am J Gastroenterol. 95 (2): 395–407. doi:10.1111/j.1572-0241.2000.01759.x. PMID 10685741.